Email ID
Password
Scrip   
Cephalon feels the pain as forecasts drop
28 October 2009
Simon Varcoe

Cephalon has lowered its full-year sales guidance despite its third-quarter revenues increasing by 9% to $535 million.

The company's central nervous system (CNS) and oncology franchises performed particularly well, increasing in sales by 7% to $292 million and 58% to $83 million respectively....



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36